Form 4 Filing for Ashland Inc.

This filing details transactions made by Alessandra Faccin Assis, SVP and GM, Life Sciences at Ashland Inc. On July 27, 2026, Assis acquired 3,215 shares of Common Stock at a price of $66.38 per share. Additionally, Assis disposed of 884 shares of Common Stock, also at $66.38 per share, to cover tax liabilities. The filing also reports the disposal of 3,215 Restricted Stock Units, with a transaction price of $0.0, which were converted into Common Stock. Following these transactions, Assis directly owns 8,215 shares of Common Stock and has 9,646 Restricted Stock Units. Footnote F1 indicates that the balances include additional shares or RSUs acquired in lieu of cash dividends. Footnote F2 clarifies that the disposal of 884 shares was for tax withholding related to RSU vesting. Footnote F3 states that each RSU represents one share of Common Stock. Footnote F4 provides details on a grant of 15,234 RSUs on July 25, 2024, with a vesting schedule over three years, contingent upon continued employment.